AI-generated summary
The authors compared a 1550 nm Er:Glass fractional laser with a fractional radiofrequency microneedle device for facial atrophic acne scars in 40 randomized patients, each receiving three treatments at 4-week intervals. Scar severity improved in both groups, by a mean of 25.0% and 18.6%, with no significant side effects reported, and the difference between the two treatments was not statistically significant.
- Participants
- 40
- Who or what was studied
- Patients with facial atrophic acne scars
- Wavelengths
- 1550 nm
- Limits stated in the abstract
- The abstract does not describe a control group or the sample size per facial compartment, and it reports a difference in effectiveness favoring the laser without statistical significance.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1550 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.